PBMCs obtained from eight preoperative CAD patients were exposed to two different doses of selenium and were also subsequently stimulated with LPS and nigericin to activate the caspase-1 pathway and were further determined for the therapeutic role of selenium on the (i) levels of IL-1β and (ii) cleaved caspase-1 (p20). The gene discussed is IL1B; the disease is coronary artery disorder.